In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus.
about
Antiviral therapy for genital herpes for prevention of HIV transmissionThe effects of antiviral therapy of genital herpes in HIV-infected individualsAbsence of rapid selection for acyclovir or penciclovir resistance following suboptimal oral prodrug therapy of HSV-infected miceA rapid phenotypic assay for detection of acyclovir-resistant varicella-zoster virus with mutations in the thymidine kinase open reading frameDiverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia.Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.Rapid phenotypic characterization method for herpes simplex virus and Varicella-Zoster virus thymidine kinases to screen for acyclovir-resistant viral infection.Current recommendations for the treatment of genital herpes.The clinical manifestations and treatment of sexually transmitted diseases in human immunodeficiency virus-positive men.Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and managementGenotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals.Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir.Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis.Penciclovir cream--improved topical treatment for herpes simplex infections.Oral and perioral herpes simplex virus type 1 (HSV-1) infection: review of its management.Acyclovir diphosphate dimyristoylglycerol: a phospholipid prodrug with activity against acyclovir-resistant herpes simplex virus.Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence.Herpes simplex virus 2 infection: molecular association with HIV and novel microbicides to prevent disease.Inhibition of clinical pathogenic herpes simplex virus 1 strains with enzymatically created siRNA pools.Herpes simplex virus type 1 virion-derived US11 inhibits type 1 interferon-induced protein kinase R phosphorylation.Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir.Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS.2017 European guidelines for the management of genital herpes.Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients."The end of innocence" revisited: resistance of herpesviruses to antiviral drugs.Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues.2014 UK national guideline for the management of anogenital herpes.Characterization of herpes simplex virus type 1 thymidine kinase mutants selected under a single round of high-dose brivudinSusceptibility of drug-resistant clinical herpes simplex virus type 1 strains to essential oils of ginger, thyme, hyssop, and sandalwood.Antiherpetic properties of acyclovir 5'-hydrogenphosphonate and the mutation analysis of herpes virus resistant strains.Intravenous immunoglobulins suppress the recurrences of genital herpes simplex virus: a clinical and immunological study.Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir.Recurrent aciclovir-resistant herpes simplex in a child with Wiskott-Aldrich syndrome.
P2860
Q24234315-0AEEBFFD-5D2C-4138-8C9F-E4665697D01DQ24245937-377CAAFB-5539-4FBA-A1A8-6F7A8EF48E20Q24797196-731606E7-6E8A-470D-A0A1-52A809A00DCCQ28344045-BD9CA33F-6955-41FD-9608-0EAB666B44A0Q30831284-9C565B49-C364-4EFD-9C80-59D96538ABACQ33749111-33C9DA80-ECEC-48C5-875F-1AD594F8972AQ33966906-8FECFA0B-C25C-4CF6-8641-2CEF68B0A9C2Q34127423-810E29B0-E6CE-48E3-8966-DAEB94B92D25Q34142034-CBC6D3D9-8CFF-48E2-B938-59752F5988F8Q34149904-69B446F5-8CC8-4FD7-BF6A-A130A2297C0DQ34290117-04748107-14AA-4FCD-A818-A91E988D246CQ34918273-99CEE9DC-0300-4EA4-897D-9A0B4CEC9429Q34938781-0D0CDB81-7471-490C-9385-7BCCD37AC9AFQ35809290-EEE67FDF-7453-4206-AC4E-BEF3F13C4B95Q35903494-878B1FEE-36D5-4DD9-A443-8E09112FB783Q36478736-C25F91EC-3140-4533-9BB0-757A6A5B2100Q36729136-6B6ACF4D-1226-4501-BE1E-E619CEA685D5Q37713430-68B5B186-83EA-4684-AF9B-EC923085FA9EQ38248209-6DFB21BE-8D02-4DAB-B6A6-718C124184C3Q38770194-B65780C9-EA4D-45A2-83A6-5A2DAED3784CQ39138722-29C3E181-72B4-4DCC-833F-128270DD3F82Q39879440-62D5502F-F30F-4D29-86DB-6E36FD4B93EBQ40044028-34EAB34F-BC56-48EB-AA3A-5EFA0E81ADE5Q40072392-06992BF7-A652-4233-8DB6-58ED3B7683D0Q40222954-EA2E1CB5-93FF-4C59-86B4-62CB6088FF4DQ40720231-E329D251-DDE6-40BC-89E7-4AC8667903FBQ40905765-331E29E1-8495-4238-AE08-ACF61694AD34Q41345018-CE64022F-9A2B-41C0-8E6B-F8D44957B53AQ41891671-9CABF3EE-6291-43AC-90AE-C390339BF0A4Q42015623-EDEDC9EC-88AF-4479-B793-95A8888FB428Q43289689-65592895-E06B-4D45-BF94-EFEF2C5FEDB2Q44503087-71FB708C-7609-4447-9142-ACFC9C6116C9Q45777522-BE9D74D0-EBEF-474C-95E9-425DFDB64FC0Q54122093-BD77E30A-9564-4F37-93C9-A0BB100220CE
P2860
In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
In vitro and in vivo character ...... human immunodeficiency virus.
@en
type
label
In vitro and in vivo character ...... human immunodeficiency virus.
@en
prefLabel
In vitro and in vivo character ...... human immunodeficiency virus.
@en
P2093
P2860
P356
P1476
In vitro and in vivo character ...... human immunodeficiency virus.
@en
P2093
P2860
P304
P356
10.1128/AAC.35.11.2322
P407
P577
1991-11-01T00:00:00Z